Clinical Approaches Involving Thrombopoietin to Shorten the Period of Thrombocytopenia After High-Dose Chemotherapy

This publication has 64 references indexed in Scilit:

• Recent advances in defining the hematopoietic stem cell niche
  Current Opinion in Hematology, 2004
• Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis
  Nature Medicine, 2003
• Recombinant human thrombopoietin: basic biology and evaluation of clinical studies
  Blood, 2002
• The residual megakaryocyte and platelet production in c-Mpl–deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor
  Blood, 2000
• Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.
  Proceedings of the National Academy of Sciences, 1995
• The stromal cells' guide to the stem cell universe
  The International Journal of Cell Cloning, 1995
• c-Mpl ligand is a humoral regulator of megakaryocytopoiesis
  Nature, 1994
• Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia [editorial]
  Blood, 1992
• Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily.
  Proceedings of the National Academy of Sciences, 1992
• A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors
  Cell, 1990